Trial
NCT04344444
Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
LCMC Health
Collaborators
—
Condition
COVID-19
Intervention
Hydroxychloroquine
Why stopped
Lack of efficacy data from other studies
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-01-21